Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are...
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book ...
This book analyses the relationships among product safety strategy and culture, concurrent engineering, new product development (NPD) processes and product safety performance.
This book analyses the relationships among product safety strategy and culture, concurrent engineering, new product development (NPD) processes and pr...
